←Neurology
Acute stroke & TIA
📚
📚 Library › 🧠 Neurology › Vascular
⏱️

Acute stroke & TIA

Inpatient stroke code, tenecteplase or alteplase, thrombectomy to 24 h, BP targets and secondary prevention (AHA 2026).

stroketenecteplasethrombectomyTIADAPT
🗓️ Reviewed 2026-11-18 · ⏱️ 4 min read · 📖 2026 AHA/ASA acute ischemic stroke guideline · 2021 AHA/ASA secondary prevention · 2022 AHA/ASA ICH guideline
🧠 Pathophysiology in 60 seconds🔎 Diagnosis💊 Management⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Last known well (LKW) is the clock. Call the stroke code, check glucose, get non-contrast CT + CTA.
  • Disabling deficit ≤4.5 h, no contraindication → IV tenecteplase 0.25 mg/kg (max 25 mg) or alteplase 0.9 mg/kg. 2026: both first-line.
  • Large-vessel occlusion → thrombectomy up to 24 h — plan lysis and EVT in parallel.
  • BP: <185/110 before lysis, <180/105 for 24 h after. No lysis → permissive up to 220/120.
  • Minor stroke (NIHSS ≤3) or high-risk TIA → DAPT (aspirin + clopidogrel) × 21 days, then single agent.

🧠 Pathophysiology in 60 seconds

⌄
  • Artery blocked → core (dead) + penumbra (stunned, salvageable). Penumbra dies by the minute: ~1.9 million neurons/min.
  • Causes (TOAST): large-artery atherosclerosis, cardioembolic (AF!), small vessel (lacunar), other (dissection, vasculitis, hypercoagulable), cryptogenic/ESUS.
  • TIA = transient symptoms without infarct on MRI. High early stroke risk (most in 48 h).
  1. 0–4.5 h 💉 IV tenecteplase 0.25 mg/kg (max 25 mg) or alteplase 0.9 mg/kg — if disabling deficit and no contraindication
  2. 0–24 h 🧲 LVO on CTA → thrombectomy (EVT); lysis and EVT planned in parallel
  3. 4.5–24 h 🖼️ Selected patients with salvageable tissue on advanced imaging may still get lysis
  4. After 🩺 BP <180/105 for 24 h after lysis; swallow screen; antiplatelet at 24 h (if no lysis bleed)

🔎 Diagnosis

⌄
  • NIHSS (0–42). Disabling = would stop the patient from basic activities or work (aphasia, hemianopia, weakness), even if NIHSS low.
  • Imaging: non-contrast CT (bleed?) → CTA head/neck (LVO?) → CT perfusion/MRI for late windows.
  • Mimics: hypoglycemia, seizure (Todd's), migraine, sepsis/toxic, conversion, old stroke "unmasked."
  • ABCD² for TIA: Age ≥60 (1), BP ≥140/90 (1), Clinical: weakness (2) / speech only (1), Duration ≥60 min (2) / 10–59 (1), Diabetes (1). ≥4 = high risk.
Major lysis contraindications (check full list)
Intracranial hemorrhage on CT · ischemic stroke/head trauma <3 months · intracranial surgery <3 months · GI bleed <21 days · platelets <100 k · INR >1.7 · therapeutic LMWH <24 h · DOAC within 48 h (unless normal specific level/reversal) · BP not controlled · glucose <50 (treat and reassess)

💊 Management

⌄
  • Tenecteplase 0.25 mg/kg single bolus (max 25 mg) — not 0.4 mg/kg (harm).
  • Or alteplase 0.9 mg/kg (max 90 mg): 10% bolus, rest over 60 min.
  • BP before lysis: labetalol 10–20 mg IV, nicardipine 5 mg/h titrate, clevidipine.
  • No antithrombotics for 24 h after lysis; repeat CT at 24 h.
  • Angioedema (ACEi users) → stop infusion, methylprednisolone, diphenhydramine, famotidine; airway.
  • Symptomatic ICH after lysis → stop, cryoprecipitate 10 U, TXA, neurosurgery.
  • Swallow screen before anything by mouth.
  • Glucose 140–180. Treat fever. Head of bed by aspiration risk.
  • DVT prophylaxis: intermittent pneumatic compression (CLOTS-3) ± LMWH (after 24 h if lysed).
  • Workup: MRI, vessel imaging, TTE (± bubble), telemetry → long-term monitor if cryptogenic, A1c, lipids.
  • PT/OT/speech; rehab planning.
Situation Therapy
Minor stroke / high-risk TIA Aspirin + clopidogrel 21 days (load clopidogrel 300–600 mg)
Other non-cardioembolic Aspirin or clopidogrel
AF DOAC; start early: within 48 h for minor/moderate, ~day 6–7 for major (ELAN, OPTIMAS)
Symptomatic carotid stenosis 70–99% CEA within 2 weeks (stenting selected)
All High-intensity statin, LDL <70 (TST) · BP <130/80 · smoking cessation · diabetes control
PFO + young cryptogenic PFO closure (selected)
  • SBP target ~140 (keep 130–150; avoid big drops).
  • Reverse anticoagulation: warfarin → 4F-PCC + vit K · factor Xa → andexanet or 4F-PCC · dabigatran → idarucizumab.
  • No platelet transfusion for antiplatelet ICH (PATCH) unless surgery.
  • Neurosurgery for cerebellar ICH >3 cm, hydrocephalus.

⚠️ Pitfalls

⌄
  • Waiting for labs (except glucose) or MRI before tPA/TNK.
  • Treating BP to "normal" in the first days without lysis → infarct growth.
  • Letting a patient eat before swallow screen → aspiration pneumonia.
  • Heparin drips for acute stroke (no benefit, more bleeding).

🎓 Board corner

⌄
Stem Answer
Aphasia, LKW 2 h ago, BP 200/110 Lower BP <185/110 → thrombolysis
NIHSS 2, non-disabling, LKW 1 h Antiplatelet (DAPT), not lysis
M1 occlusion, LKW 14 h, good perfusion mismatch Thrombectomy
TIA, 80% ipsilateral carotid stenosis CEA within 2 weeks
Stroke + new AF, small infarct Start DOAC within ~48 h

📚 References

⌄
  • Prabhakaran S, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2026. doi:10.1161/STR.0000000000000513
  • Kleindorfer DO, et al. 2021 Guideline for Prevention of Stroke in TIA/Stroke. Stroke. 2021;52:e364.
  • Greenberg SM, et al. 2022 Guideline for Spontaneous ICH. Stroke. 2022;53:e282.
  • POINT · CHANCE · ELAN · OPTIMAS · CLOTS-3.
↩︎ Back to 🧠 Neurology